Efficacy and Safety of Cycloset® Compared With Placebo When Added to Metformin
Status:
Terminated
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy and safety of Cycloset® and placebo
when added to metformin monotherapy (at least 1000 mg/day for 3 months prior to screening) in
persons with type 2 diabetes mellitus who are not adequately controlled on metformin therapy
alone.